Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0268
-0.0012 (-4.29%)
Aug 6, 2026, 11:35 AM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $7.29 million as of August 6, 2026. Its market cap has decreased by -65.32% in one year.
Market Cap
7.29M
Enterprise Value
-4.58M
Revenue
5.92M
Ranking
n/a
PE Ratio
0.29
Stock Price
$0.03
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 7.29M, a decrease of -99.40%. That is a compound annual growth rate of -36.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 7.29M | 5.77% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 13.90M |
| Synlogic | 13.80M |
| Anebulo Pharmaceuticals | 13.05M |
| Zeo ScientifiX | 10.96M |
| Brainstorm Cell Therapeutics | 8.52M |
| Curative Biotechnology | 8.22M |
| Zenith Capital | 7.99M |
| TRON Group | 7.36M |